These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9153164)
21. Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection. Webber KM; Bowen R; Casadesus G; Perry G; Atwood CS; Smith MA Acta Neurobiol Exp (Wars); 2004; 64(1):113-8. PubMed ID: 15190686 [TBL] [Abstract][Full Text] [Related]
22. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. Zhao L; Brinton RD BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397 [TBL] [Abstract][Full Text] [Related]
23. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease. Inestrosa NC; Marzolo MP; Bonnefont AB Mol Neurobiol; 1998; 17(1-3):73-86. PubMed ID: 9887447 [TBL] [Abstract][Full Text] [Related]
24. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Gibbs RB; Aggarwal P Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621 [TBL] [Abstract][Full Text] [Related]
25. The role of estrogen replacement therapy in Alzheimer's disease. Panidis DK; Matalliotakis IM; Rousso DH; Kourtis AI; Koumantakis EE Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):86-91. PubMed ID: 11267726 [TBL] [Abstract][Full Text] [Related]
27. Estrogens and hormone replacement therapy: is there a role in the preservation of cognitive function? Bieber EJ; Cohen DP Int J Fertil Womens Med; 2001; 46(4):206-9. PubMed ID: 11563830 [TBL] [Abstract][Full Text] [Related]
28. [Estrogens and Alzheimer disease]. Stähelin HB Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084 [TBL] [Abstract][Full Text] [Related]
29. Can variability in the hormonal status of elderly women assist in the decision to administer estrogens? Kuchel GA; Tannenbaum C; Greenspan SL; Resnick NM J Womens Health Gend Based Med; 2001 Mar; 10(2):109-16. PubMed ID: 11268296 [TBL] [Abstract][Full Text] [Related]
30. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease. Casadesus G; Garrett MR; Webber KM; Hartzler AW; Atwood CS; Perry G; Bowen RL; Smith MA Drugs R D; 2006; 7(3):187-93. PubMed ID: 16752944 [TBL] [Abstract][Full Text] [Related]
31. Oestrogens and dementia. Henderson VW Novartis Found Symp; 2000; 230():254-65; discussion 265-73. PubMed ID: 10965513 [TBL] [Abstract][Full Text] [Related]
32. The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers. Miller KJ Curr Psychiatry Rep; 2003 Dec; 5(6):439-44. PubMed ID: 14609498 [TBL] [Abstract][Full Text] [Related]
33. [Dementia: risk and protective factors with special consideration of gender and hormone replacement therapy]. Stoppe G Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):217-22. PubMed ID: 10802897 [TBL] [Abstract][Full Text] [Related]